Varenicline Tablet, Film Coated
Product Images NDC 50090-7135

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Varenicline (NDC 50090-7135). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500907135)

Label for varenicline tablets, 0.5 mg strength, film-coated, oral dosage form. The label shows the product by A-S Medication Solutions with NDC 50090-7135. It states each tablet contains varenicline tartrate equivalent to 0.5 mg varenicline free base and includes storage instructions to store at 68 to 77 degrees Fahrenheit and protect from light. The package contains 56 tablets.*

FDA Label Image

Var-fig-1 (Var Fig 1)

A bar chart divided into four study sections comparing the efficacy percentages of varenicline 0.5 mg BID, varenicline 1.0 mg BID, varenicline flexible dose, bupropion SR 150 mg BID, and placebo. Each study section shows bars with corresponding percentages on the y-axis ranging from 0% to 60%, indicating comparative treatment outcomes with error bars displayed for variability.*

FDA Label Image

Var-fig-2 (Var Fig 2)

A bar chart comparing percentage values across four studies (Study 2, Study 3, Study 4, Study 5). Each study presents data for varenicline at various dosages or formulations and placebo, with Study 4 and 5 also including bupropion. The bars represent different treatment groups, with error bars indicating variability.*

FDA Label Image

Var01 (Var01)

Chemical structure of varenicline tartrate, showing the varenicline moiety with an attached tartrate group. The diagram depicts the molecular arrangement including nitrogen heterocycles and functional groups present in the compound.*

FDA Label Image

Var04 (Var04)

A line graph showing the percentage of continuous abstinent individuals over weeks of nontreatment follow-up, comparing varenicline tablets 1.0 mg BID versus placebo. Percent continuous abstinent is plotted on the vertical axis and weeks on the horizontal axis, with varenicline consistently showing higher abstinence percentages than placebo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.